AN HIV/AIDS MUSS NIEMAND STERBEN!

Zum Weiterlesen:

Die folgenden Studien belegen den Erfolg und die Probleme der HIV/AIDS Therapie in Afrika.

VIELES von dem was heute wissenschftlich belegt ist, haben wir in Bulongwa in Zusammenarbeit mit Ärzten ohne Grenzen bereits 2004/2005 durchgeführt oder angestrebt. In der Folge von massiven Menschenrechtsverletzungen durch die Lutherischen Kirche in Tansania, wurde in den letzten beiden Jahren alles wieder schlechter und vor allem auch Kinder können nicht mehr richtig behandelt werden.

Antiretrovirale Medikamente arbeiten für jeden Menschen, egal ob Schwangere, Kind, Mann oder Frau.
Jeder Mensch, der diese Medikamente auf Grund von Diebstahl von Gesundheitsressourcen nicht bekommt, oder auf Grund von Nepotismus, Plünderungen von Konten und Korruption (die dazu dient, alle Untersuchungen von Polizei und Gerichten zu unterbinden), keine guten Ärzte und Krankenhäuser zur Verfügung hat, wird sterben - wird einen unnötigen Tod sterben.

Transparency International beschäftigt sich seit langem mit Korruption und deren negativen Folgen für das Gesundheitssystem.

Im Bulongwa Lutheran Hosptital, das der ELCT (Evangelical Lutheran Church of Tanzania) gehört, sind die Behandlungszahlen seit April 2006, als das erfolgreiche HIV/AIDS Behandlungsprogramm des EAWM (Evangelischer Arbeitskreis für Weltmission) durch die korrupte und kriminelle ELCT gewaltsam aus dem Krankenhaus geworfen wurde, stetig gesunken, anstatt wie vorgesehen gestiegen. Der Bedarf für die Therapie ist bei einer vermuteten HIV Rate von 15% unvermindert hoch.

Kinder können nicht mehr ausreichend behandelt werden und statt ausreichender Mutter-Kind-Programme und der Verhinderung von Neuansteckungen mit der HIlfe der segensreichen Medikamente, gibt die diebische Kirche stolz zu Protokoll, dass sie sich um Waisenkinder kümmert. Deren Eltern sie hat sterben lassen.

Die Waisenkinder sehen vom eingesammleten Geld auch oft nichts und dass Mama Kikwete (die Frau des Tansanischen Präsidenten) bei ihrem Besuch in Makete verärgert war, als sie Waisenkinder interviewte und dass die anwesende Ehefrau des US Botschafters weinte, angesichts der Aussagen der Kinder, dass sie keine Hilfe bekämen, das sollte den Bischöfen und den Missionsdirektoren aus Deutschland eigentlich zu denken geben.

Ich denke aber, dass Kirchenvertretern und besonders Missionsdirektoren jener lutherischen Organisationen, die seit Jahrzehnten lokale afrikanische Bischöfe und Kirchenvertreter füttern, ohne ausreichende Nachweise für die Verwendung der eingesetzten Ressourcen zu fordern, in alterprobter Manier immer wieder neue Unwahrheiten und Propaganda gegen jene Menschen aus Afrika einfällt, die gegen die Misstände in der kriminellen Kirche kämpfen. Die Kinder und Verwandten dieser ehrlichen Amerikaner werden derweil weitersterben. Afrikadirektor Volker Schauer vom NMZ wird es nicht weiterstören, er wird weiter Respekt für sich fordern und sich neue Lügen über die Situation in Tansania ausdenken.

Ich hoffe, dass sich die Kirche in Tansania, Deutschland und Österreich der kriminellen Strukturen und ihrer Förderer irgendwann entledigt. Ich denke, dass das ihre Pflicht wäre und dass Menschen positive Vorbilder brauchen. Vor allem in Zeiten wie diesen.


Southern Africa: a long road to male circumcision

Looking to get circumcised to reduce your risk of HIV infection? If you’re living in Southern Africa, you might have a long wait until services become more widely available.
Read More >>

Study highlights bootlenecks in ARV supply in West Africa

In West and Central Africa, large amounts of money are spent on buying antiretroviral (ARV) drugs but weak distribution systems mean many HIV-positive patients never get them, said speakers at the 15th International Conference on AIDS and STIs in Africa (ICASA) in Dakar, Senegal, last week.
Read More >>

Botswana expects HIV treatment numbers to reach 225,000 by 2016

Botswana’s government expects the number of citizens receiving antiretroviral therapy (ART) to increase by more than 50% in the next eight years, reaching 220,000 by 2016, President Ian Khama said last week.
Read More >>

Community support improves HIV treatment outcomes for patients in South Africa

Community support initiatives significantly improve responses to antiretroviral therapy amongst patients in South Africa, a study published in the November 30th edition of AIDS shows. The research also showed that baseline characteristics were also important for the first six months, and the investigators suggest that community support is particularly valuable at this time for patients who start HIV treatment with a low CD4 cell count and high viral load.
Read More >>


Promising early results for large-scale study of community-level HIV prevention initiative

Uptake of voluntary counseling and testing increased dramatically in intervention communities during the first two years of a community-randomised controlled HIV prevention study in four countries, according to an article in the December 1st edition of the Journal of Acquired Immune Deficiency Syndromes. Project Accept seeks to reduce HIV transmission by changing community norms through a combination of community mobilisation activities; high-quality HIV mobile voluntary counseling and testing (VCT); and post-test support services.
Read More >>

Fluconazole shown to be more effective against cryptococcal meningitis at higher dose

A small Ugandan study has shown that 1200mg of fluconazole per day appears to be a better treatment for cryptococcal meningitis than 400 to 800mg per day, which is the dosage typically administered to patients in many African health facilities. The study was reported in the December 15th edition of Clinical Infectious Diseases.
Read More >>


Different paediatric responses to antiretroviral therapy in Uganda and the United Kingdom/Ireland may reflect differences in nutrition and access to cotrimoxazole

Researchers have reported that while HIV-positive children in Uganda and the United Kingdom/Ireland responded similarly to antiretroviral therapy in most regards, the Ugandan children lagged behind in CD4 cell recovery and body growth. The study, published in the December 1st issue of Journal of Acquired Immune Deficiency Syndromes, calls attention to the potential for malnutrition and opportunistic infections to undercut the benefits of antiretroviral therapy.
Read More >>

Children starting HIV treatment in sub-Saharan Africa have a low risk of death

There is a low risk of death for children starting HIV treatment in sub-Saharan Africa, an international team of investigators report in the December 15th edition of the Journal of Acquired Immune Deficiency Syndromes. The risk of death after starting HIV treatment was 7% and three-quarters of deaths occurred in the six months after antiretroviral therapy was started.
Read More >>


HIV testing for mothers and children must expand, UN report shows

Access to HIV testing and antiretrovirals for prevention of mother to child HIV transmission has grown substantially over the past four years in the countries most severely affected by HIV, UN agencies reported today – but around 40% of women in the high prevalence countries of southern Africa are still not being offered an HIV test during pregnancy.
Read More >>

Traditional healers could play key role in ART rollout

Traditional healers could potentially be an important source of HIV treatment in some African settings, according a study published in the December 1st edition of AIDS. Investigators from Zimbabwe and the University of Pennsylvania found that patients reported better quality of life after a visit to a traditional healer than did patients who accessed orthodox medical services.
Read More >>

Mbeki's opposition to ARVs cost 330,000 lives, shows study

The refusal of the Mbeki government to roll-out antiretroviral therapy and treatment to prevent mother-to child transmission in South Africa resulted in 330,000 needlessly premature HIV-related deaths and 35,000 avoidable case of mother-to-child HIV transmission according to estimates published in the December 1st edition of the Journal of Acquired Immune Deficiency Syndromes.
Read More >>

Universal testing and treatment could reduce new HIV infections in southern Africa by 95% in 10 years

Universal HIV testing and immediate antiretroviral therapy for everyone diagnosed with HIV in a country with very high HIV prevalence could reduce new infections from 20 per thousand to 1 per thousand within ten years (a 95% reduction), according to findings from a mathematical modelling exercise carried out by the World Health Organization, published on November 26th by The Lancet.
Read More >>

Excellent outcomes from five years of antiretroviral use in Botswana

The first five years of a large-scale antiretroviral programme have resulted in excellent, sustained rates of virologic suppression, CD4 cell count increases, and improved clinical outcomes among adults in Botswana, according to a study reported in AIDS.
Read More >>

CD4 cell count increases sustained up to five years in developing-world treatment programmes

According to a large-scale collaborative analysis reported in AIDS, antiretroviral programmes have led to significant and sustained increases in CD4 cell counts among people in low-income countries who are able to remain on therapy. Among nearly 20,000 people receiving antiretroviral therapy (ART) in African, Latin American, and Asian study cohorts, median CD4 cell counts increased from a baseline of 114 cells/mm3 to 395 cells/mm3 after five years on treatment.
Read More >>